Night-time oral insulin therapy

Details for Australian Patent Application No. 2004204727 (hide)

International Classifications

Event Publications

21 July 2005 PCT application entered the National Phase

PCT publication WO2004/062587 Priority application(s): WO2004/062587

19 October 2006 Application Accepted

Published as AU-B-2004204727

9 November 2006 Corrigenda

Applications Accepted - Name Index Under the name Emishere Technologies, Inc., Application No. 2004204727, under INID (71) correct the name to read Emisphere Technologies, Inc.

22 February 2007 Standard Patent Sealed

4 August 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

1 September 2011 Section 223 Application Received

Emisphere Technologies, Inc. An application to extend the time from 06 Jan 2011 to 06 Aug 2011 in which to pay a continuation fee has been filed . Address for service in Australia - Griffith Hack Level 19 109 St Georges Terrace Perth WA 6000 2006

27 October 2011 Section 223 Application Allowed

Emisphere Technologies, Inc. The time in which to pay a continuation fee has been extended to 06 Aug 2011. Address for service in Australia - Griffith Hack Level 19 109 St Georges Terrace Perth WA 6000 2005

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.